Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on Lichen Planus
NCT ID: NCT02453503
Last Updated: 2015-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
60 participants
INTERVENTIONAL
2014-01-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods and materials :The study was randomized by double-blind clinical trial . Patients with symptomatic OLP who referred to the Oral Medicine School of Dentistryin Medical Sciences in Isfahan University participated voluntarily. The patients were divided into two groups that were including 30 samples in each group. The first group was treated with triamcinolone mucoadhesive film and the second group were treated with licorice mucoadhesive film. Data were analyzed by using the Mann-Whitney test and t-test in SPSS software.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Clinical Efficiency of Photodynamic Therapy and Topical Corticosteroid in Treatment of Oral Lichen Planus
NCT04976673
Evaluating Treatment Efficacy in Oral Lichen Planus: The Role of Salivary Biomarkers
NCT06332365
Topical Erythropoietin Hydrogel in Management of Oral Lichen Planus
NCT06135259
Efficacy of Ginger Muco-bioadhesive Gel in Management of Oral Lichen Planus With Immunohistochemical Analysis
NCT05882864
Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen Planus
NCT02443311
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Although, these lesions rarely are life-threatening , discomfort and pain associated with abnormal caloric intake lead to nervosa, dehydrated in short order and malnutrition. It also increases the risk of infection and reduce the quality of life in patients greatly.(2,3). The main treatment for symptomatic OLP is prescribing systemic or topical corticosteroids . (1,3) and its strong type like triamcinolone has been increasingly used in the treatment of OLP (4).
Lichen planus is a chronic mucocutaneous disease and relatively common in middle-aged that affected 2- 0.2% of the population. Men and women are almost equally affected. In the mouth, white bilatera lesions sometimes cause wound The most common clinical pattern is linear (9-5) .There is a limited study in the frequency and clinical forms of OLP.
It can be mention to Esmaeili etal study that patients in men and in fourth decades is most common and Hypertrophic and classic type are more and the type of reticular in oral lesions is more prevalent (10)and in another study by Khalili etal reported that the most common form of clinical lesion is ulcerated lesion and the average time spend 18.4 months, most commonly involving mucosa is the buccal and then the tongue and gums .White spots, lines Wickham and mucosal erythema are the most common clinical features of the lesion (11).
There is currently no cure for OLP. The main focus of treatment is to reduce the duration and severity of symptoms. The most common and acceptable treatment for symptomatic OLP lesions and systemic corticosteroids or topical is to modulate the host immune response .In mild to moderate lesions the main treatment is by topical corticosteroids such as clobetasol gel, betamethasone gel and triamcinolone ointment (2, 3, 12). Due to the persistence of the drug at the site of the lesion may be used new dosage form of mucoadhesive such as tablets or film. Films are from mucoadhesive drug delivery systems that have been used in the manufacture of mucoadhesive polymers and have received considerable attention in recent years .The films can be attached on the oral wound healing and cause to reduce pain and inflammatory diseases. (4, 13)
The Licorice plant have been used in traditional medicine for the treatment of aphthous ulcers, gastric ulcers, hepatitis C, cough, Asthma, Addison and skin diseases. Clinical pharmacology studies have shown that this herb also contains beneficial anti-inflammatory components, antiviral and antibacterial, antioxidant, anticancer and modifying the immune system is .Licorice contains a provision, glycyrrhetinic acid and glycyrrhizin which helps in healing wounds (14,15,16) In 2008, Martin et al. examined the effects of oral patch containing licorice extract (Licorice) for the treatment of aphthous ulcers and found positive effects on the size of the lesion and the patient's report of pain. (15) Chan et al., investigated palliative treatment of patients with symptomatic OLP such as steroids, Cyclosporine and topical retinoid in a systematic review and concluded that there are only weak evidence for the superiority of this treatment compared with placebo . The authors also expressed several studies has been faced with restrictions in which various compounds with potentially useful results on the OLP.
Conducted studies were not enough strong , the control group was small, making blind about the researcher or patient didn't do in them or have been made errors in designing the study. There would be special need to statistically powerful studies in order to determine the value of new compounds in the prevention or treatment of mucositis .(17)
The purpose of this study is to find a way to reduce pain and inflammation in patients with symptomatic OLP On the one hand and reduce the risk of infection, reduce the need for pain medication and ultimately improve the quality of life by using triamcinolone mucoadhesive films or licorice in this group of patients.
Methods and materials:
This study was a clinical trial and randomized as double-blind. Sampling was done randomly Patients with symptomatic OLP who referred to the Oral Medicine School of Dentistryin Medical Sciences in Isfahan University participated voluntarily.. In this study, patients with symptomatic OLP over 18 years both men and non-pregnant women enrolled in the study and . All patients were examined for dental Prophylaxis and oral hygiene and recommendations about compliance with oral health have been done for all patients . After filling written consent , the patients were divided into two groups randomly :first group I (n = 30) will be treated with triamcinolone Mucoadhesive film and the second group (n = 30) will be treated with licorice mucoadhesive film.
All patients underwent a complete dental examination and diagnosis of patients with oral lichen planus lesions initially marked by physical examination and conducted by interviewing with patients and then confirmed by histologic evaluation .The duration of treatment or recovery of lesions was two weeks as the weekly visits.
The Triamcinolone Mucoadhesive film with 1 mg was prepared and provided to patients in one group. And another group was given licorice mucoadhesive film by Afnogel brand name .The drug dose was determined three times a day after meals and before bed time that patients put it in the upper part of gum after eating and washing mouth and the patient can do common function like talking and eating and drinking within releasing the drug.
Severity and recovery rate of lesions were measured in each visit in accordance with the criteria that set in Buajeeb etal(18) from 0 to 5 degrees .The rate of pain in patients that created by Mucositis assessed by ruler and VAS method and it was given a number from 0 to 10 according to the rate of pain.
Injury or burning ,pain on waking, eating, drinking, talking, pain when swallowing, dry mouth, tingling or numbness after taking the studied medication and using the products containing caffeine, tobacco, and alcohol in the questionnaire registered by the patient .The compliance of patients were evaluated based on the returned mucoadhesive at the end of each week and based on the number of patients' visits to physicians. The patient withdrew from the study for any reason, pregnancy, drug interactions, compliance less than 70% patients about taking the medicine o has been done by referring to the doctor .All of the cases were collected and analyzed by the Mann-Whitney test.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Triamcinolone acetonide
Triamcinolone acetonide mucoadhesive films 1 mg every 6 hours for two weeks.
Triamcinolone Acetonide
Triamcinolone acetonide mucoadhesive films 1 mg every 6 hours for two weeks.
Licorice
Licorice mucoadhesive films 1 mg every 6 hours for two weeks.
Licorice
licorice mucoadhesive films evey 6 hours for two weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Licorice
licorice mucoadhesive films evey 6 hours for two weeks
Triamcinolone Acetonide
Triamcinolone acetonide mucoadhesive films 1 mg every 6 hours for two weeks.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All non pregnant women
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Isfahan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mehdi Nasr Isfahani
Director
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
394115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.